Mr Francesco Giganti
MBBS, PhD
GMC: 7471579
- Medical Degree - Vita-Salute San Raffaele University, Milan
- PhD in Prostate MRI - University College London (2021)
- Clinical Radiology Training - Vita-Salute San Raffaele University
- English
- Italian
- French
- Prostate MRI for diagnosis and staging
- Active surveillance (PRECISE score)
- Prostate image quality assessment (PI-QUAL score)
- MRI after focal treatment (PI-FAB score)
- MRI–ultrasound fusion technology for precision diagnostics and treatment planning
- Teaching and training in prostate MRI interpretation
A UK leader in prostate cancer care
Christos has studied at leading institutions across the UK and is currently a clinical oncologist at Mount Alvernia Hospital in Guildford. He treats people with a range of cancers but has particular expertise in radiotherapy, including stereotactic ablative radiotherapy and prostate brachytherapy. At The Focal Therapy Clinic, he is a key member of our MDTs and helps people choose the right treatment for them.
Christos is also at the cutting edge of prostate cancer research. In addition to treating patients, he is co-investigator and developer of a number of studies at the Institute of Cancer Research, including the GENPROS study (investigating how genetic factors impact outcomes), the GENPET study (an imaging study looking at men with different genetic mutations) and the BARCODE-1 study (where 5,000 men will be genetically profiled and the highest risk individuals will be offered a diagnostic prostatic biopsy).
Research and publications
- Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study). European Radiology. 2025. DOI: 10.1007/S00330-025-11837-1
- Magnetic Resonance Imaging–led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. European Urology. 2025;88(2):167–175. DOI: 10.1016/j.eururo.2025.03.019
- Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility Phenomenon. European Urology Open Science. 2025;72:36–41. DOI: 10.1016/j.euros.2025.01.010
- Prostate MRI Using the PI-RR Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis. European Urology Oncology. 2024. DOI: 10.1016/j.euo.2024.05.007
Learn more about Focal Therapy and Prostate Cancer
Finasteride and prostate cancer: what evidence shows
8 Prostate Cancer Myths Debunked – UK Specialist Guide
What Causes Prostate Cancer Inequality in the UK – and What You Can Do?
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.
